Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-550-1 | CAS number: 108-10-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1984
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 984
- Report date:
- 1984
- Reference Type:
- publication
- Title:
- Mutagenicity studies on ketone solvents: methyl ethyl ketone, methyl isobutyl ketone and isophorone
- Author:
- O'donoghue JL, Haworth SR, Curren RD, Kirby PE., Lawlor T et al.
- Year:
- 1 988
- Bibliographic source:
- Mutat. Res., 206, 149-161
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- yes
- Remarks:
- - only one dose used instead of 3.
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- 4-methylpentan-2-one
- EC Number:
- 203-550-1
- EC Name:
- 4-methylpentan-2-one
- Cas Number:
- 108-10-1
- Molecular formula:
- C6H12O
- IUPAC Name:
- 4-methylpentan-2-one
- Details on test material:
- - Name of test material (as cited in study report): Methyl Isobutyl Ketone
- Physical state: Clear, colourless liquid
- Analytical purity: 99.56%
- Stability under test conditions: Not reported
- Storage condition of test material: Not reported
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- CD-1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Breeding Laboratory
- Age at study initiation: 6-8 weeks
- Weight at study initiation: 29-37 g (males) and 22-27 g (females)
- Assigned to test groups randomly: yes, under following basis: computer-generated random number table
- Fasting period before study: Not reported
- Housing: housed up to six per cage in plastic autoclavable cages with wire lids. Hardwood chips were used for bedding.
- Diet (e.g. ad libitum): Animals had free access to a certified laboratory rodent chow which had been analyzed for environmental contaminants.
- Water (e.g. ad libitum): Water was provided ad libitum
- Acclimation period: Not reported
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 76 ± 6ºF (approximately 24 ºC)
- Humidity (%): 50 ± 20%
- Air changes (per hr): Not reported
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil
- Details on exposure:
- The test article-vehicle mixture and the vehicle alone were administered by I.P. injection at a rate of 10 mL/kg body weight. The positive control, TEM, was injected IP at a dose level of 0.25 mg/kg. All mice in the experimental and control groups were weighed immediately prior to dose administration and the dose volume based on individual body weights. Animals were observed after dose administration for clinical signs of chemical effect.
- Duration of treatment / exposure:
- 12, 24, or 48 hours (single exposure: animals killed at 12, 24, or 48 hours)
- Frequency of treatment:
- Single administration
- Post exposure period:
- 12, 24, or 48 hours
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0.73 mL/kg bw
Basis:
- No. of animals per sex per dose:
- 5/sex/dose/time point
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- triethylenemelamine
- Route of administration: IP
- Doses / concentrations: 0.25 mg/kg
Examinations
- Tissues and cell types examined:
- Bone marrow cells from the femurs.
- Details of tissue and slide preparation:
- At the scheduled sacrifice time, five mice/sex were sacrificed by cervical dislocation. Immediately following sacrifice, the femurs were exposed, cut just above the knee, and the bone marrow was aspirated into a syringe containing FBS. The bone marrow cells were transferred to a capped centrifuge tube containing approximately 1 mL cold FBS. The bone marrow cells were pelleted by centrifugation at approximately 1000 rpm for five minutes and the supernatant was drawn off, leaving a small amount of serum with the remaining cell pellet. The cells were resuspended by aspiration with a capillary pipette and a small drop of bone marrow suspension was spread onto a clean glass slide. Two to four slides were prepared from each animal. The slides were aged overnight and stained with May-Gruenwald-Giemsa and permanently mounted.
- Evaluation criteria:
- 1000 polychromatic erythrocytes were scored for the presence of micronuclei. The number of micronucleated normocytes in the field of 1000 polychromatic erythrocytes was also enumerated. The ratio of normochromatic to polychromatic erythrocytes was recorded as the proportion of polychromatic erythrocytes per total erythrocytes.
The ratio of normochromatic to polychromatic erythrocytes is presented for each animal and treatment group as the proportion of polychromatic erythrocytes per total erythrocytes. The incidence of micronuleated polychromatic erythrocytes per 1000 polychromatic erythrocytes is presented for each animal and treatment group. An analysis of variance was used to compare the incidence of micronucleated polychromatic erythrocytes of the treatment group and solvent control groups.
The incidence of micronucleated erythrocytes per 1000 polychromatic erythrocytes must not exceed 0.5% in the negative (vehicle) control. The incidence of micronucleated polychromatic erythrocytes in the positive control group must be at least twice that of the negative control and significantly increased (p~0.05) relative to the negative control using t-test statistics. - Statistics:
- The test article is considered to induce a positive response if a treatment-related increase (p<0.05, one-way ANOVA, Duncan’s multiple range test) in micronucleated polychromatic erythrocytes is observed relative to the vehicle control. All data, including reproducibility, was evaluated and a final judgment made on sound scientific basis.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- 2/18 male and 4/18 female mice died prior to scheduled sacrifice. Test article treated animals appeared heavily sedated immediately following administration (no other clinical signs of toxicity were observed).
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
- Executive summary:
In a non-GLP micronucleus assay (equivalent to OECD guideline 474), MIBK was administered via intraperitoneal (IP) injection to male and female CD-1 mice at a dose of 0.73 mL/kg body weight. Corn oil was used as the vehicle and triethylenemelamine was administered via the IP route as the positive control compound. Mice were sacrificed at 12, 24, or 48 hours following injection of test article or control (5 mice/sex/time point). Two male mice and 4 female mice died following test article administration and animals receiving MIBK appeared heavily sedated. No other clinical signs of toxicity were observed and no statistically significant increases in the number of micronucleated polychromatic erythrocytes were noted at any time point. Injection of the positive control caused the anticipated increase in micronucleated polychromatic erythrocytes. The use of only 1 dose level instead of the recommended 3 rendered this study reliable with restrictions.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.